Operating Expenses
Total Operating Expenses
Bristol-Myers Squibb Total Operating Expenses decreased by 13.2% to $9.11B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 10.8%, from $10.22B to $9.11B. Over 3 years (FY 2021 to FY 2024), Total Operating Expenses shows an upward trend with a 14.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Rising expenses without a corresponding rise in revenue can indicate operational bloat or aggressive expansion efforts.
Detailed definition
The sum of all costs required to run the business that are not directly tied to production, including R&D and SG&A. It r...
Peer comparison
Investors compare this to revenue to assess the 'operating leverage' of a business model.
Metric ID:
is_total_operating_expensesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.15B | $9.47B | $10.13B | $9.96B | $9.93B | $9.01B | $9.55B | $8.57B | $9.37B | $8.83B | $9.80B | $23.38B | $10.92B | $10.22B | $12.17B | $8.23B | $10.50B | $9.11B |
| QoQ Change | — | -6.7% | +7.0% | -1.6% | -0.3% | -9.3% | +6.0% | -10.3% | +9.3% | -5.7% | +11.0% | +138.5% | -53.3% | -6.4% | +19.1% | -32.4% | +27.5% | -13.2% |
| YoY Change | — | — | — | — | -2.2% | -4.8% | -5.7% | -14.0% | -5.7% | -2.0% | +2.7% | +172.9% | +16.5% | +15.7% | +24.1% | -64.8% | -3.8% | -10.8% |
Range$8.23B – $23.38B
CAGR-2.5%
Avg YoY Growth+8.4%
Median YoY Growth-3.0%
Total Operating Expenses at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total operating expenses?
- Bristol-Myers Squibb (BMY) reported total operating expenses of $9.11B in Q3 2025.
- How has Bristol-Myers Squibb's total operating expenses changed year-over-year?
- Bristol-Myers Squibb's total operating expenses decreased by 10.8% year-over-year, from $10.22B to $9.11B.
- What is the long-term trend for Bristol-Myers Squibb's total operating expenses?
- Over 3 years (2021 to 2024), Bristol-Myers Squibb's total operating expenses has grown at a 14.0% compound annual growth rate (CAGR), from $38.29B to $56.68B.
- What does total operating expenses mean?
- The total cost of running the day-to-day business, excluding the direct cost of making products.